Time-Restricted Eating Cuts Liver Fat as Effectively as Calorie Restriction
A 16-week RCT finds TRE reduces hepatic steatosis by ~26% in MASLD patients — matching calorie restriction with no serious side effects.
Summary
A randomized controlled trial of 333 adults with metabolic dysfunction-associated steatotic liver disease (MASLD) compared time-restricted eating (TRE), calorie restriction (CR), and standard of care over 16 weeks. TRE reduced liver fat by 25.8% versus a 0.7% change with standard care. Crucially, TRE performed on par with calorie restriction across all major outcomes — liver fat, body weight, waist circumference, body fat mass, and metabolic markers. Sleep quality and liver stiffness were also similar between TRE and CR. No serious adverse events occurred. These findings position TRE as a practical, flexible dietary strategy for managing MASLD, especially for patients who find traditional calorie counting difficult to sustain.
Detailed Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver condition worldwide, closely tied to obesity, insulin resistance, and poor metabolic health. Lifestyle intervention remains the cornerstone of treatment, but adherence to calorie restriction is notoriously difficult. Time-restricted eating — limiting food intake to a defined daily window without necessarily counting calories — has emerged as a promising alternative, but clinical evidence in MASLD specifically has been scarce until now.
This 16-week randomized controlled trial enrolled 337 overweight or obese adults with confirmed MASLD, randomizing them 1:1:1 to standard of care, calorie restriction, or TRE. The primary endpoint was change in hepatic steatosis measured via MRI-proton density fat fraction, a highly accurate and objective imaging tool. Secondary endpoints included liver stiffness, body composition, lipid and glucose profiles, and sleep quality.
TRE produced a 25.8% reduction in liver fat compared to just 0.7% in the standard care group — a highly significant difference. Importantly, TRE was statistically equivalent to calorie restriction (-24.7%), suggesting both dietary strategies are similarly potent for reducing liver fat. Body weight, waist circumference, and body fat mass all improved significantly more with TRE than standard care, again matching CR. Liver stiffness, glucose homeostasis, and sleep quality were comparable between TRE and CR groups.
These findings are clinically meaningful because TRE imposes a structural eating pattern rather than demanding precise calorie tracking, potentially improving real-world adherence. For MASLD patients struggling with conventional dietary advice, TRE offers a simpler, flexible framework with equivalent metabolic benefit.
Caveats include the 16-week duration, which limits conclusions about long-term efficacy, fibrosis reversal, and sustainability. The trial was conducted in a Korean population, so generalizability to other ethnicities warrants investigation. The specific TRE eating window protocol and level of dietary counseling support provided are also important context not fully detailed in the abstract.
Key Findings
- TRE reduced hepatic steatosis by 25.8% vs. 0.7% with standard care over 16 weeks.
- TRE and calorie restriction produced equivalent reductions in liver fat, body weight, and body fat.
- Liver stiffness, glucose homeostasis, and sleep quality were similar between TRE and CR groups.
- No serious adverse events were reported in any group across the 16-week trial.
- 333 of 337 randomized MASLD patients completed the full analysis, supporting robust findings.
Methodology
16-week three-arm randomized controlled trial (n=333) comparing TRE, calorie restriction, and standard of care in overweight/obese MASLD patients. Primary outcome was hepatic steatosis measured by MRI-proton density fat fraction. Registered on ClinicalTrials.gov (NCT05579158).
Study Limitations
The 16-week duration does not allow conclusions about long-term outcomes such as fibrosis reversal or disease progression. The study population was Korean, limiting generalizability to diverse ethnic groups. Details on the specific TRE eating window duration and adherence monitoring are not fully described in the available abstract.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.